Craig A. Collard, CEO: Heron Therapeutics HRTX Buy · Filed 23/11/17

Trade details

Type: Insider buy
Amount: $138,000
Shares · price: 150,000 sh · $0.92 a share
Held after: 186,496 sh
Stock: Heron Therapeutics HRTX
Person: Craig A. CollardCEO
Trade date: 23/11/16
Filed: 23/11/17
Days to filing: 1 days

3 insiders bought this week

Insiders buying this week: 3 insiders
Holding change: +411.0%

Heron Therapeutics trades, last 26 weeks

What else happened in Heron Therapeutics around then

Filed or reported within 30 days of the trade day · 23/10/17~23/12/16

Craig A. Collard's recent trades

No other trades yet.